UIC report: Potential COVID-19 drug may increase risk for cardiac events
Azithromycin, a commonly prescribed antibiotic being investigated as a potential treatment for COVID-19, can cause potential cardiac events if taken with other drugs, according to a new report from the University of Illinois Chicago.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
